BOSTON SCIENTIFIC CORPORATION Other than Temporary Impairment Losses, Investments
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other than Temporary Impairment Losses, Investments of $16.00 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2011-02-17
- BOSTON SCIENTIFIC CORPORATION other than temporary impairment losses, investments for the quarter ending 2010-12-31 was $17.00M.
- BOSTON SCIENTIFIC CORPORATION other than temporary impairment losses, investments for the quarter ending 2010-09-30 was -$5.00M.
- BOSTON SCIENTIFIC CORPORATION other than temporary impairment losses, investments for the quarter ending 2010-06-30 was -$4.00M.
- BOSTON SCIENTIFIC CORPORATION other than temporary impairment losses, investments for the quarter ending 2010-03-31 was $8.00M.
- BOSTON SCIENTIFIC CORPORATION other than temporary impairment losses, investments for fiscal 2010 was $16.00M.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|---|---|
| 2010-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $12.00M derived: sum of 2 quarters · filed 2011-02-17 | $8.00M derived: sum of 3 quarters · filed 2011-02-17 | $16.00M 10-K · filed 2011-02-17 |
| 2010-09-30 | -$5.00M 10-Q · filed 2010-11-05 | -$9.00M derived: sum of 2 quarters · filed 2010-11-05 | -$1.00M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | -$4.00M 10-Q · filed 2010-11-05 | $4.00M derived: sum of 2 quarters · filed 2011-02-17 | ||
| 2010-03-31 | $8.00M derived: 10-K 12 month − 3 quarters · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |